Abstract-The effects of crude platycodin on the coronary and hindquarter vascular beds in anesthetized dogs were studied and compared with those of glyceryl trinitrate, papaverine and Saponin (E. Merck AG.). Crude platycodin in doses of 200 to 800 &mu; g i.a. dose-dependently reduced coronary and hindquarter vascular resistances and the potency was comparable to that of papaverine. Crude platycodin, 4 mg/kg i.v., also caused an increase in coronary and hindquarter blood flows, concomitantly with a transient systemic hypotension.
papaverine and Saponin (E. Merck AG.). Crude platycodin in doses of 200 to 800 &mu; g i.a. dose-dependently reduced coronary and hindquarter vascular resistances and the potency was comparable to that of papaverine. Crude platycodin, 4 mg/kg i.v., also caused an increase in coronary and hindquarter blood flows, concomitantly with a transient systemic hypotension.
The vasodilating effect of crude platycodin appears to be direct and non-specific on the peripheral blood vessels as in the case of glyceryl trinitrate or papaverine.
A Chinese medicine "Jiegeng" (Japanese name: Kikyo), the roots of Platycodon grandi florurn A. DC., has been frequentlyy administered to patients with cough and/or bronchitis as an expectorant. Crude platycodin, a saponin fraction separated from the methanolic extracts of the roots (1) has been shown to have anti-inflammatory, anti-ulcer, vasodilating and expectorant activities in experimental animals (2) (3) (4) . The marked inhibitory effect of crude platycodin on gastric secretion and experimental ulcerations have also been re ported (5) .
In the present studies, the effects of crude platycodin on peripheral circulation in cluding the coronary and hindquarter vascular beds in anesthetized dogs were investigated and compared with those of glyceryl trinitrate, papaverine and Saponin (E. Merck AG.),
MATERIALS AND METHODS
Male mongrel dogs weighing 10 to 15 kg were anesthetized with sodium pentobarbital, 35 mg/kg i.v. The trachea was cannulated and the animals were artificially ventilated with room air using a positive pressure respirator (Natsume, KN-50). The chest was opened at the left fourth intercostal space, and the heart was exposed. After hepari.niza tion (500 unit/kg i.v.), the left anterior descending coronary artery was proximally ligated, distally cannulated and perfused with blood led from the left common carotid artery through polyvinyl tubing and an electromagnetic flowmeter (Nihon Kohden, MF-2). The right femoral arterial blood pressure was obtained via a pressure transducer (Nihon Kohden, MPU-0.5) and recorded together with coronary blood flow on a polygraph (Nihon Kohden, For the measurement of femoral blood flow, pentobarbitalized and heparinized dogs as mentioned above were utilized. The left femoral artery was exposed and cannulated in its proximal portion, the blood led from the cannula was streamed into another cannula inserted into the distal portion of the artery through polyvinyl tubing and an electromag netic flowmeter.
The following parameters were calculated: coronary vascular resistance=mean femoral arterial blood pressure (mmHg)/mean coronary blood flow (ml/min), and hindquarter vascular resistance=mean femoral blood pressure (mmHg)/mean femoral blood flow (ml/min).
Each drug solution having no influence on systemic blood pressure was injected close to the perfusing artery in a volume of 0.4 ml in 10 sec.
In some experiments, the effects of intravenously administered agents on the coronary and hindquarter vascular beds were examined. The blood flow through the left anterior descending coronary artery or the left femoral artery was measured with a flow probe (inter nal diameter: 2 to 3 mm, Nihon Kohden) positioned around the corresponding vessel.
The flow probe signals were fed into an electromagnetic flowmeter (Nihon Kohden, MF 5) , and recorded together with femoral arterial blood pressure and heart rate obtained via a cardiotachometer (Nihon Kohden, RT-2) triggered by the femoral arterial pulse on a polygraph. Each drug solution was injected into the left cephalic vein through an inserted catheter and was flushed with 1 ml of physiological saline.
Crude platycodin, readily soluble in water and a pale-yellowish brown powder with a bitter taste, mainly consisted of saponins, and was prepared by Akiyama et al. (1) . Glyc eryl trinitrate (0.01 % aqueous solution, Nihon Kayaku Co.), papaverine hydrochloride (Iwaki Seiyaku Co.), Saponin (E. Merck AG.), isoproterenol hydrochloride (Kaken Chemi cal Co.), histamine dihydrochloride (Wako Pure Chemicals Co.), acetylcholine chloride (Daiichi Seiyaku Co.), atropine sulfate (Wako Pure Chemicals Co.), diphenhydramine hydrochloride (Tokyo Kasei Co.), propranolol hydrochloride (Sumitomo Chemical Co.) and crude platycodin were freshly dissolved in physiological saline in the required con centrations. The dose of the drugs was expressed in terms of the salt.
RESULTS

Effect on the coronary vascular bed
The effects of crude platycodin in doses of 200, 400 and 800,ng i.a. on the coronary vascular bed were examined in comparison with those of glyceryl trinitrate, 2, 4 and 8 It" i.a., papaverine and Saponin, 200, 400 and 800 , g i.a. All these agents exerted a dose dependent vasodilating effect on the coronary vascular bed. Typical data are shown in Fig. 1 . In ten separate experiments performed on different dogs, the maximum effects of crude platycodin, 200, 400 and 800 /2g La., were 53.5±3.0 (S.E.), 64.1 1.9 and 65.5:i _ 1.7% decreases in coronary vascular resistance, respectively, as shown in Fig. 2 In three dogs, crude platycodin, 4 mg/kg i.v., also caused an increase in coronary blood flow, as shown in Fig. 3 . Saponin, 4 mg/kg i.v., exerted a similar effect but less potent than that of crude platycodin. In three dogs, crude platycodin, 4 mg/kg i.v., also exerted an increase in femoral blood flow, concomitantly with a transient fall in systemic blood pressure, as shown in Fig. 6 .
Saponin, 4 mg/kg i.v., and glyceryl trinitrate, 5 ,cog/kg i.v., showed a similar effect but less potent than that of crude platycodin. Papaverine, 1 mg/kg i.v., produced a more marked increase in femoral blood flow than the other three agents.
1Vleclanisni involved in vasodilating effect
To study the mechanism involved in the vasodilating effect of crude platycodin on the coronary and hindquarter vascular beds, the following experiments were performed.
Influence of treatment with atropine, 2 mg/kg, diphenhydramine, 3 mg/kg, or pro pranolol, 0.5 mg/kg i.v., on the vasodilating effect of crude platycodin, 400 ,ug i.a., ad ministered into the coronary or hindquarter vascular bed was observed and compared with those of glyceryl trinitrate, 4 It-, papaverine, 400 ,ug, and Saponin, 400 ,ug i.a. Each corresponding blocking effect of these blocking agents was verified by the administrations of acetylcholine, 0.1 ,ug, histamine, 0.1 It-, and isoproterenol, 0.1 jig i.a., respectively.
Crude platycodin, 400 /tg i.a., induced 50 to 60 % increase in coronary vascularr resistance in six dogs, and no significant change after treatment with each blocking agent was ob served, as is shown in Fig. 7 . In the case of glyceryl trinitrate, papaverine and Saponin, no influence of treatment with atropine, diphenhydramine or propranolol was observed.
Similar results were obtained from experiments on hindquarter vascular resistance in six animals, as shown in Fig. 8 
DISCUSSION
Crude platycodin is a crude saponin fraction isolated from platycodi radix and ap parently contains a specific component of this oriental plant which has been used as a Chi nese medicine (1).
As the result of a semi-quantitative trial carried out in order to clarify the therapeutic effects of platycodi radix in Chinese medicine, platycodi radix was shown to be mainly prescribed for patients with various inflammatory diseases (6) . This plant has also been used for its expectorant, analgesic, antipyretic, hypotensive and antitussive effects. Fur thermore, sedative, anti-ulcer, antigastritic and anti-allergic effects of the plant have oc casionally been observed.
On the other hand, crude platycodin has revealed anti-inflammatory, anti-ulcer, vaso dilating and expectorant effects as main pharmacological activities in experimental ani mals. Analgesic, antipyretic, antitussive and anticholinergic effects have also been ob served (2) (3) (4) .
In the present studies, close-arterially administered crude platycodin showed a vasodi lating effect on coronary and hindquarter vascular beds autoperfused in pentobarbitalized dogs.
From the results of per cent decreases in both peripheral vascular resistances, the vasodilating potency of crude platycodin in doses used was comparable to that of papa verine, and significantly superior to that of Saponin (E. Merck AG.). Furthermore, crude platycodin clearly showed increases in coronary and femoral blood flows, even when ad ministered intravenously.
It is widely recognized that coronary blood flow may be influenced by a change in cardiac contractile force. Crude platycodin, even in a relatively high concentration (1 x 10-3 to 3 x 10-3 g/ml), has been shown to cause only a mild depression of contractile force in isolated guinea pig atria (4). For this reason, an increase in coronary blood flow in duced by crude platycodin in doses utilized herein, does not appear to be due to a change in contractile force, although this force was not measured in the present studies.
A relatively significant hemolytic activity of crude platycodin has been observed: crude platycodin is 1.2 times stronger than Saponin (E. Merck AC.) in hemolytic index (2) . Whether or not the vasodilating effect observed is influenced by hemolytic activity is unclear.
Although experiments on vascular beds other than the coronary and hindquarter
have not been carried out, crude platycodin appears to have no specific vasodilating effect on a particular vascular bed, since the agent showed the activity in both coronary and hindquarter vascular beds in almost the same degree.
To determine the vasodilating mechanism of crude platycodin, some blocking agents, including atropine, diphenhydramine and propranolol, were utilized.
Since there was no influence by these blocking agents on the responses induced by crude platycodin as well as by glyceryl trinitrate, papaverine or Saponin, the mechanism through muscarinic, histamine-like or beta-adrenergic effect may be ruled out from the point of vasodilating activity.
Crude platycodin appears to have a direct vasodilating activity on the blood vessels as in the case of glyceryl trinitrate or papaverine, although more detailed experi ments on the mechanism involved in the vasodilating effect are required for confirmation.
